February 2022 - Page 11 of 26

ThursdayFeb 17, 2022 11:25 am

QualityStocksNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) to Ring Bell, Open NASDAQ Market Today

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance Micro Motion Technology(R) (“MMT”) lidar solutions was scheduled to ring the opening bell on the market today at 9:15 a.m. ET. The ceremonial bell-ringing activity marks the company’s official public listing on the NASDAQ market, which was a week ago on Feb. 11, 2022. Cepton CEO and cofounder Dr. Jun Pei was slated to ring the bell; he was to be joined by cofounder and chief technical officer Dr. Mark McCord as well as George Syllantavos and Akis Tsirigakis, co-CEOs from the company’s SPAC partner Growth Capital Acquisition Corp.…

ThursdayFeb 17, 2022 11:18 am

QualityStocksNewsBreaks – AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) Expands Corporate Efforts as It Advances Closer to Market with Milestone Products

AREV Life Sciences (CSE: AREV) (OTC: AREVF) today announced new corporate acquisitions and maturation of multiple product lines being matched with appointments and expanding corporate capacity in the company’s scientific advisory committee and IP council. The company has appointed Douglas Sorocco to its scientific advisory committee and IP council and has extended services with Strategic Health Resources LLC. These moves come as AREV’s expanding consumer products and therapeutic innovations pipeline enters mature stages of development. “These new additions to AREV’s corporate efforts assure acceleration of the enterprise’s immediate goals as we come closer to market entry with milestone products,” said…

ThursdayFeb 17, 2022 11:04 am

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Shareholder Letter

Mullen Automotive (NASDAQ: MULN) CEO and chair David Michery recently outlined company highlights and accomplishments in a shareholder letter; he specifically mentioned the company’s Mullen FIVE and EV Van Crossover programs. Mullen went public on Nov. 5, 2021, and since then it has filed more than 120 patents in 24 countries covering the Mullen FIVE EV Crossover and purchased Tunica’s AMEC manufacturing facility. In addition, the company debuted the Mullen FIVE at the Los Angeles International Auto Show, where the innovative vehicle won the best SUV ZEVAS(TM) Award; an extensive consumer EV market study also had the Mullen FIVE scoring…

ThursdayFeb 17, 2022 11:00 am

Cepton Inc. (NASDAQ: CPTN) Completes Merger, Brings Next Generation Lidar to Public

Cepton completed a merger with SPAC Growth Capital Acquisition Corp. and began trading on the NASDAQ Capital Markets on February 10, 2022 Cepton is a maker of next generation lidar technology that has significant advantages over competition The company’s MMT(R) technology has been validated by Tier 1 automotive OEMs and earned the company the lidar industry’s biggest contract to date where GM will use Cepton products in its cars equipped with its new Ultra Cruise ADAS Apart from Tesla, companies are aligning with lidar companies to improve safety in advanced driving technology and position for the seemingly inevitable age of…

WednesdayFeb 16, 2022 3:21 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Launches New eCommerce Website – HearingAssist.com

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer hearing technology space, today announced the launching of a new eCommerce website for HearingAssist, a wholly-owned subsidiary of InnerScope, located at www.HearingAssist.com. The new website showcases a transformative redesign that offers an industry leading digital experience with a new eCommerce platform. “I am thrilled to announce HearingAssist's new website, which provides us greater opportunities for growth by helping our existing customers and reaching potential new customers,” said Matthew Moore, president and CEO of InnerScope. “Considerable thought and time have gone into the front and back-end of this…

WednesdayFeb 16, 2022 3:18 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc.’s (CSE: RWB) (OTCQX: RWBYF) Warren Facility Providing Centralized Distribution, Production Capacity to Expand Sales

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) has received full licensing for manufacturing both medical and adult-use cannabis products in Michigan, a state entering its third year under legislation allowing the legal sale of adult recreational-use cannabis. In addition, a recent article notes, “The company has closed on a lease assignment for a 15,000-square-foot manufacturing, processing and distribution facility in Warren, Michigan, which is part of RWB’s strategic planned acquisition of 18 Michigan dispensaries, four cultivation facilities and other significant real estate announced in September.” RWB CEO and Chairman Brad Rogers comments: “This Warren facility allows us to…

WednesdayFeb 16, 2022 3:15 pm

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Featured in Latest Episode of Bell2Bell Podcast

SPYR (OTCQB: SPYR) (dba SPYR Technologies), a technology company whose subsidiary, Applied Magix Inc., develops and resells Apple(R) ecosystem compatible products in the growing multibillion-dollar IoT smart home and connected car markets, was featured in the Bell2Bell Podcast, a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. Dr. Harald Zink, CEO, founder and chief product architect of SPYR, joined the latest episode to discuss Applied Magix’s business model, management team and operational goals. “Our basic business plan for the first year of operations was to establish a framework and a foundation for what…

WednesdayFeb 16, 2022 2:03 pm

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Announces FY 2021 Results

Kaival Brands (NASDAQ: KAVL) is the exclusive global distributor of products manufactured by Bidi Vapor LLC, including the BIDI(R) Stick disposable electronic nicotine delivery system (“ENDS”), intended exclusively for adults 21 and over. The company today reported its fiscal 2021 results and provided an update in which its Chief Executive Officer Niraj Patel recapped 2021 and offered insight into expansion strategies for 2022. “Fiscal year 2021 was a very challenging year, especially because of FDA's marketing denial order, or MDO, for Bidi Vapor's non-tobacco flavored BIDI (R) Stick ENDS, which caused irreparable harm to both Bidi Vapor and Kaival Brands.…

WednesdayFeb 16, 2022 1:47 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Evolution to Commercial Sales to Health and Wellness Market Featured in Research Report

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, was featured in a report published by Edison Group, a leading research and investor relations consultancy. According to the piece, InMed achieved Q222 financial results that reflect its evolution from a pure-play biotech firm to one with commercial sales to the health and wellness market, with revenues of $0.3 million, all cannabichromene (“CBC”). “As of January, it also began selling cannabicitran (‘CBT’) to the health and wellness market,” notes the report. “The now-completed BayMedica acquisition boosts its product portfolio for rare cannabinoids and rounds…

WednesdayFeb 16, 2022 1:26 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Adds Novel Molecule to Family of Psilocin Analogs

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, has included a novel molecule — MYCO-005 — which has potential for heart-safe microdose enabling properties, to its psilocin analogs. The company submitted a patent application covering multiple families of psilocin analogs late last year, noting that these second-generation molecules address delivery and stability concerns with the first-generation compounds. According to the company, its research findings show the potential for a psilocin analog that may be considered a heart-safe microdose drug, which is a substance consumed at a low enough…

Site Search

Company Search

Month: February 2022